Stanley G. Rockson, MD
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
Contact Information
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Brief
To better understand the mechanisms leading to lymphedema development in breast cancer survivors, and the implications for potential innovative approaches to the screening, prevention and treatment of this condition.
Recruiting Status:
No longer recruitingStanford Recruiting Status:
No longer recruitingCondition(s):
Intervention(s):
Phase:
N/AEligibility
Ages Eligible for Study:
18 years to Any AgeGenders Eligible for Study:
FemaleHealth of Volunteers:
People with the conditions listed in this trial can participate as controls.Key Inclusion Criteria:
- Patients enrolled in the proposed studies must be survivors of breast cancer at a time point at least 4 years following the initial surgery and radiotherapy for the disease.
- Patients must have a history of unilateral axillary lymph node dissection.
- Patients referred to, or that receive their care within the Stanford University Breast Cancer Program and the Stanford Center for Lymphatic and Venous Disorders.
- Patients will be required to have the capacity to provide informed consent.
Key Exclusion Criteria:
- Patients with other serious systemic illness (renal failure, hepatic dysfunction, congestive heart failure, neurological or psychological impairment) that would confound the study or impair the patients' ability to participate.
- Patients will not be enrolled if they are taking drugs that affect carbohydrate metabolism.
- Patients with recurrent breast cancer or other forms of pre-existing lymphedema will be ineligible.
Additional Study Details
Official Title:
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2Anticipated start date:
7/12/2005Lead Sponsor:
Stanford UniversityCollaborator(s):
- BCRP
Investigator(s):
Study Type:
ObservationalPurpose:
NOTNEEDEDDuration:
Cross-sectionalSelection:
Defined PopulationTiming:
RetrospectiveTotal Number to be Enrolled:
30Total Number to be Enrolled at Stanford:
30More Information
Secondary ID(s):
- 96204
- BRSNSTU0009
- NCT00383604
Locations & Contacts
Stanford Locations & Contacts:
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Non-Stanford Locations:
The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.
This listing was last updated:
9/30/2009PLEASE NOTE:
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.
Help